Chronic kidney disease
Tracked across 1 events · 12 articles · First seen Jun 03, 2026 · Last active Jun 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Chronic kidney disease is a long-term condition affecting over 850 million people globally, and the FLOW trial's findings on Semaglutide offer a significant improvement in the quality of life for patients with this condition.
Jun 03, 2026 · 12 articles
NEWSDESK
Track Chronic kidney disease live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard